This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,845.19 firm fixed-price delivery order contract is for the provision of TAVALISSE 150 MG TABLET 60S, a pharmaceutical product, with a completion date of January 3, 2025.
The contract is not designated as a set-aside award. It is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000, for similar medical products and prescription drugs.
Generated 3/12/25, 9:54 AM